CNBX Cannabics Pharmaceuticals has an agreement with Purisys, a leading Active Pharmaceutical Iingredient manufacturer, to use its API in Phase I/II (a) clinical studies that it is planning to launch in 2022. So this year will be quite bullish for CNBX Cannabics Pharmaceuticals is a U.S. public company and a global leader in the development of cancer related...
Seems to be at a low with the RSI lining up nicely as well. I think we have 30% minimum here. Good luck!
Based on idea from @CryptoFundManager Buy on small retrace and ride up. Entry at 0.55. SL at 0.47 PT at 1, because it's a round number.
Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad...
Looking at CNBX looks like its moving out of consolidation. I expect a target around 0.60. TSI over zero is positive. It's overbought, but it can stay that way. AB=CD pattern in play.
I was stupid to buy at 1,6 in July. I bought more than 1000 pca and I wait 29.12 to sell!! Double stupid man and now 2,4 more or less!! I 'm thinking that some stocks about marijuana will be go and come back to the stars because I saw a lot of Grow in this sector from Dicember. I m out with this stock....I don't go in more!!
CNBX has broken the 2014 high with a strong impulse. If it consolidates above the level posted on chart i'm expecting one more wave up for a multi year breakout. A strong breakdown under that level can be the beginning of a huge correction.
Breakout Historical RES. $0.245